|
Canada-0-Financing 公司名錄
|
公司新聞:
- Scholar Rock | Discovery and Development of Innovative Medicines
At Scholar Rock, we are on a mission to discover, develop, and deliver therapies to improve people’s lives We are a biopharmaceutical company combining bold science with a deep commitment to make a meaningful difference for people living with serious diseases
- Our Pipeline - Scholar Rock
Our Pipeline Our pipeline runs on breakthrough science Scholar Rock is turning scientific discoveries into a pipeline of investigational therapies aimed at diseases where growth factors play a central role Our therapeutic approach selectively targets the latent forms of growth factors, which can get to the underlying biology of many serious diseases We apply this […]
- Our Company - Scholar Rock
Our Company We work every day to create possibilities for patients Since our beginning, we have been dedicated to discovering, developing, and delivering therapies that create new possibilities for patients Improving lives is the foundation of all that we do Scholar Rock was founded on pioneering science from researchers at Harvard Medical School and Boston Children’s […]
- Press Releases - Scholar Rock, Inc.
Explore Scholar Rock's latest press releases, financial results, and business updates, showcasing their commitment to innovative medicine development
- Investors Media | Scholar Rock
Investors and Media Corporate Profile Scholar Rock (NASDAQ: SRRK) is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of […]
- Contact Us - Scholar Rock
Scholar Rock and its third party providers deploy appropriate technical and organizational safeguards to protect your personal information, and data processing services are performed in accordance with all applicable regulatory requirements
- Clinical Trials | Scholar Rock
Clinical Trials The process from lab to patient We believe in our investigational medicines and their potential to change patients’ lives Clinical trials are a critical step in bringing a new therapy from our in-house laboratory to the world Read below for important background information and the most recent updates on our clinical trials Jump to: […]
- Mission Vision - Scholar Rock
Mission Vision We show up for patients, each and every day Our mission Our mission is to discover, develop, and deliver life-changing therapies by harnessing cutting-edge science to create new possibilities for people with serious diseases that have high unmet need Our vision Our vision is to be a global leader in discovering and […]
- Believe in What is Possible - Scholar Rock
Hear how members of the SMA community navigate the challenges of living with SMA as they share stories of overcoming adversity, finding strength and embracing hope
- Scholar Rock Reports First Quarter 2025 Financial Results and . . .
Main content section Scholar Rock Reports First Quarter 2025 Financial Results and Highlights Business Progress May 14, 2025 PDF Version Apitegromab BLA accepted under priority review for patients with Spinal Muscular Atrophy (SMA) and FDA’s PDUFA date set for September 22, 2025; commercial readiness progresses European Medicines Agency validated Marketing Authorisation Application (MAA) for
|
|